NCT04975022View on ClinicalTrials.gov

A Study Evaluating the Bioavailability of Oral Insulin (N11005)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions
PK, PD, and Safety
Interventions
DRUG

N11005

oral insulin N11005, 300IU, p.o.

DRUG

Novolin R

reference preparation Novolin R, 0.1 IU/Kg, i.h.

Trial Locations (1)

Unknown

Beijing Hospital, Beijing

All Listed Sponsors
lead

Beijing Hospital

OTHER_GOV

NCT04975022 - A Study Evaluating the Bioavailability of Oral Insulin (N11005) | Biotech Hunter | Biotech Hunter